SANTA CLARA, Calif. — SecuGen, the world’s leading optical fingerprint device vendor, is pleased to announce that its Hamster Plus USB Fingerprint Reader has been selected by Schleuniger Automation for use with its CrimpCenter product line. A leading manufacturer of machines for wire processing, Schleuniger’s [...]

SAN MARINO, Calif. — Epeius Biotechnologies Corporation, an emerging leader in the field of targeted genetic medicine, gained international validation of the cutting-edge science behind its lead oncology product, Rexin-G, when scientists around the world rediscovered the Cyclin G1 gene to be a major locus [...]

SANTA CLARA, Calif. — SecuGen, the world’s leading optical fingerprint device vendor, is pleased to announce that its Windows 7 and Windows Server 2008 Release 2 device drivers for SecuGen USB fingerprint readers, the Hamster IV, Hamster Plus, OptiMouse Plus and Keyboard Plus, have passed [...]

SANTA CLARA, Calif. — SecuGen, the world’s leading optical fingerprint device vendor, is pleased to announce that Lucky Technology has selected the SecuGen(R) SDA03M(TM) standalone fingerprint sensor for Lucky’s iGuard(R) LM520-FOSC Access Control and Time Attendance device. The iGuard provides physical access control as well [...]

SAN FRANCISCO, Calif. — Epeius Biotechnologies Corporation (www.epeiusbiotech.com), an emerging leader in the field of targeted genetic medicine, announced today that Frederick L. Hall, President and CEO, and Dr. Erlinda M. Gordon, Medical Director, will be participating in the 8th Annual BIO Investor Forum being [...]

SANTA CLARA, Calif. — SecuGen, the world’s leading optical fingerprint device vendor, is pleased to announce that its USB fingerprint readers, the Hamster IV, Hamster Plus, OptiMouse Plus and Keyboard Plus, are now compatible with the Windows(R) 7 operating system. SecuGen’s family of USB fingerprint [...]

SAN MARINO, Calif. — Epeius Biotechnologies (www.epeiusbiotech.com) confirms the first real breakthrough for pancreatic cancer seen in years; publishes a landmark report of tumor-targeted Rexin-G as stand-alone therapy in chemotherapy-resistant pancreatic cancer. Following Phase I studies at the Mayo Clinic, which affirmed the general safety [...]

SAN MARINO, Calif. — Epeius Biotechnologies Corporation today announced more stunning results of its pioneering clinical studies of Rexin-G, the world’s first and, so far only, tumor-targeted genetic medicine to be validated in the clinic. Administered as stand-alone therapy in late-stage cases of chemotherapy-resistant cancer, [...]

ATLANTA, Ga. — M2SYS Technology, an award-winning biometric technology research and development firm, has finalized an agreement to provide Bwindi Community Hospital with their leading-edge fingerprint identification system as part of a donation effort to support global causes. Bwindi Community Hospital provides healthcare to some [...]

ATLANTA, Ga. — The Kaduna State Muslim Pilgrims Welfare Board will now be able to enroll more than 8,000 potential pilgrims for Hajj, and eliminate the hassle of multiple registrations from a single person. Kaduna State can also accurately verify each of the pilgrims in [...]

SANTA CLARA, Calif. — SecuGen and Valid Technologies are pleased to announce a technology and marketing partnership to deliver strong user authentication solutions to IBM enterprise computing customers. As a result of this partnership, the Valid Technologies VSSA(R) Strong User Authentication solution will include support [...]

ATLANTA, Ga. — M2SYS Technology, an award-winning biometric technology research and development firm, announced today that GHG Corporation, an innovative time tracking software provider, has chosen to provide their customers with M2SYS’ Bio-SnapON™ biometric software solution. Bio-SnapON allows GHG to instantly add biometric recognition capabilities [...]

SANTA CLARA, Calif. — SecuGen, the world’s leading vendor of optical fingerprint readers, is pleased to announce that it has released the OptiMouse(TM) Plus, an upgraded version of the world’s first combination fingerprint reader and optical mouse. Like all of SecuGen’s fingerprint readers, the OptiMouse [...]

ATLANTA, Ga. — Faith-Based information management solutions leader to provide its customers with biometric technology. M2SYS Technology, an award-winning biometric technology research and development firm, announced today that it has finalized an agreement with ACS Technologies, the leading provider of information management solutions to nearly [...]

SANTA CLARA, Calif. — SecuGen, the world’s leading optical fingerprint device vendor, is pleased to announce that it is now providing all of its industry leading fingerprint template extraction and matching SDKs free of charge. Included in SecuGen’s wide selection of Software Developer Kits are [...]

ATLANTA, Ga. — M2SYS Technology, an award-winning biometric technology research and development firm, announced today that Kronos Incorporated, the global leader in workforce management solutions, has chosen M2SYS to provide its customers with a desktop biometrics solution that seamlessly interfaces with Kronos time and attendance [...]

SAN MARINO, Calif. — Epeius Biotechnologies (www.epeiusbiotech.com) stuns the medical and scientific communities with a dramatic demonstration of single-agent efficacy with its lead product, Rexin-G, for metastatic cancer. The landmark article (accessible online as of June 16, 2009 in Molecular Therapy, the Official Journal of [...]

SANTA CLARA, Calif. — SecuGen is pleased to announce that iPulse Systems, South Africa’s leading biometrics company, has selected SecuGen’s SDA04M fingerprint module as the core fingerprint engine for the iPB6, the next generation in biometric readers. Incorporating a full LINUX operating system, and running [...]

ATLANTA, Ga. — M2SYS Technology, an award-winning fingerprint biometrics research and development firm, announced today that VinDec Enterprise Solutions has integrated M2SYS’ Bio-Plugin(TM) fingerprint software and M2-EasyScan(TM) fingerprint reader into its blood donor management system. The biometric identification system will be initially used by the [...]

SAN MARINO, Calif. — Epeius Biotechnologies announces the launch of its new informative website, containing an award-winning video and an interactive e-book designed to introduce the general public to the tumor-targeting and cancer-destroying biotechnologies behind the clinical development of Rexin-G. Honored as the first and [...]

TEMECULA, Calif. — Written Inc. today released Salesperson Insight, a new type of sales personality report that teaches salespeople how their traits are impacting their sales, what they’re communicating to their prospect through their body language and what they can do specifically to change and [...]

SAN MARINO, Calif. — Epeius Biotechnologies (epeiusbiotech.com) announced the results of a U.S. Phase I/II study evaluating the safety and efficacy of Rexin-G in chemotherapy-resistant metastatic pancreatic cancer (ASCO GI Symposium, #249; Sant P Chawla, P.I., Santa Monica CA, January 2009). Rexin-G was well tolerated [...]

SANTA CLARA, Calif. — SecuGen is pleased to announce the immediate availability of two new ultra high capacity OEM fingerprint sensors, the SDA04M(TM) and the SDA04(TM). The SDA04M is intended for commercial biometrics applications, and the SDA04 is intended for government and commercial applications where [...]

ATLANTA, Ga. — M2SYS Technology, an award-winning fingerprint biometrics research and development firm, announced today that RPGSi Business Solutions, a provider of effective and high quality technology and information systems to Latin America, has integrated M2SYS’ Bio-Plugin(TM) Appserver fingerprint software into its HealthGest(TM) healthcare software. [...]

SANTA CLARA, Calif. — SecuGen is pleased to announce that its Hamster(TM) Plus and Hamster(TM) IV fingerprint biometric readers are now compatible with Sun Solaris, Sun Ray, and Sun’s Identity Management Solutions. SecuGen’s engineering and Sun’s ISV engineering team worked closely together to provide a [...]

REDWOOD CITY, Calif. — Authernative, Inc., the developer of innovative user authentication and identity management technologies, announced today that the Australian Patent Office has granted the company a patent for a user authentication method. The newly issued patent number 2004323374 entitled, “Authentication System and Method [...]

SAN MARINO, Calif. — Epeius Biotechnologies Corporation, a leader in tumor-targeted gene delivery systems, has received two additional European patents for the platform targeting technologies and molecular designs that enable precision gene delivery to primary cancers and metastatic lesions that have spread throughout the body. [...]

ATLANTA, Ga. — M2SYS Technology, an award-winning fingerprint biometrics research and development firm, announced today that InvoTech Systems Inc., the leading provider of “back-of the-house” inventory tracking systems for the hospitality industry, has chosen M2SYS Technology to provide its customers with M2SYS’ Bio-SnapON(TM) enterprise-ready fingerprint [...]

SANTA CLARA, Calif. — SecuGen is pleased to announce that the SDA04(TM) fingerprint sensor module has been approved by the U.S. General Services Administration (GSA) for government-wide acquisition through GSA’s Approved Products List (APL) for FIPS 201 implementations. The SDA04 joins SecuGen’s Hamster IV USB [...]

SANTA CLARA, Calif. — SecuGen Corporation is pleased to announce that Biometric Technologies, Inc. has integrated the SecuGen Hamster(TM) IV into BioClaim(R), their flagship software product. BIOCLAIM is the only medical billing solution that provides biometric confirmation that a patient was actually present to receive [...]

SANTA CLARA, Calif. — SecuGen is pleased to announce that the SDA04, an advanced single finger capture device, has been certified by the FBI as compliant with the U.S. Government’s FIPS 201/PIV requirements. FIPS 201 places stringent requirements on the image quality of fingerprint devices [...]

SAN CLEMENTE, Calif. — A software grant that could lead to orthopedic surgeons being able to immediately gauge the effectiveness of implanted joints has been announced by LifeModeler, Inc. The company, a leading global provider of biomechanical human body simulation tools and services, will provide [...]

SAN MARINO, Calif. — Epeius Biotechnologies Corporation today announced that Rexin-G, its lead product in development for metastatic cancer, has been highlighted in a recent NEWS article published by the Journal of the National Cancer Institute (JNCI, Sept. 9, 2008). The article, authored by Vickie [...]

SANTA CLARA, Calif. — SecuGen is pleased to announce the immediate availability of its newest OEM fingerprint sensor module, the SDA03M. The SDA03M features a large storage capacity of 3,000 users and will perform a fast one-to-many identification in an average of 0.2 seconds at [...]

ATLANTA, Ga. — M2SYS Technology, an award-winning fingerprint biometrics research and development firm, announced today that Harms Software, a leading provider of management software to the spa and salon industry, has agreed to begin providing M2SYS fingerprint readers and software to their customers worldwide. Harms [...]

ATLANTA, Ga. — M2SYS Technology, an award-winning fingerprint biometrics research and development firm, announced today that it has reached an agreement with TimeForge, a provider of web-based scheduling and time and attendance solutions to the hospitality industry. Through the terms of this agreement, TimeForge will [...]

ATLANTA, Ga. — M2SYS Technology, an award-winning fingerprint biometrics research and development firm, announced today that it has finalized a partnership agreement with ZOLL Data Systems(R), an industry leader in the development of EMS and fire department management software, to provide fingerprint software and hardware [...]

SAN MARINO, Calif. — Epeius Biotechnologies Corporation today announced that Rexin-G has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for the treatment of all soft tissue sarcomas. This latest approval is the third clinical indication for which Rexin-G has [...]

SAN MARINO, Calif. — Epeius Biotechnologies Corporation today announced that Rexin-G has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for the treatment of osteosarcoma. Based on several criteria, including the rarity, seriousness, and current lack of effective therapies for [...]

LAS VEGAS, Nev. — The Sher Institutes for Reproductive Medicine(R) announced today that Pamela Madsen has been named as Director of Client/Practice Relations to service its 15 offices across the United States. Additionally, Ms. Madsen will be representing ReproCure, a reproductive genetics laboratory, to help [...]

SANTA CLARA, Calif. — SecuGen Corporation is pleased to announce that it has chosen AC Technology, Inc. as its primary GSA holder for the SecuGen Hamster(TM) IV and SecuDesktop(R) Pro line of FIPS 201 certified fingerprint scanners and software. The two companies have been working [...]

ATLANTA, Ga. — M2SYS Technology, an award-winning fingerprint biometrics research and development firm, announced today that it has finalized an agreement with IMCL (Innovative Marijuana Caregiver Logistics), a leading provider of inventory and patient management solutions to the medical marijuana dispensary industry. Through this agreement, [...]

DALLAS, Texas — Biometric Signature ID (“BSI”) and Quick Business Operating Systems (QBOS) today announced a strategic alliance that will enable BSI’s dynamic biometric authentication and verification solutions to seamlessly operate within QBOS’s Business Process Automation Suite of products. BSI’s solutions give businesses’ using the [...]

FAIRMONT, W.Va. — Backbone Security, the industry leader in advanced digital steganalysis tools, is pleased to announce the latest version of the Steganography Application Fingerprint Database (SAFDB), the world’s largest commercially available hash set exclusive to steganography applications. Developed in Backbone’s Steganography Analysis and Research [...]

GHENT, N.Y. — The Nature Institute has unveiled a new website designed to set the public debate about genetic engineering upon a more accessible scientific foundation. Distilling a voluminous technical literature, the website gathers together — often in the researchers’ own words — information about both the intended and unintended consequences of transgenic experiments.

SANTA CLARA, Calif. — SecuGen is pleased to announce the immediate availability of an improved version of the Hamster Plus fingerprint reader. This newly upgraded device captures fingerprint images much faster than previously. In addition, the Hamster Plus now makes the Smart Capture feature available. Smart Capture automatically adjusts the sensor brightness to capture fingerprints from dry and moist fingers that have often been difficult to scan.

ATLANTA, Ga. — M2SYS Technology, an award-winning biometric technology research and development firm, announced today that it has finalized an agreement with DAXKO, a leading provider of operations software and services to the YMCA market. The agreement will benefit YMCAs and their members by speeding the flow of critical information and increasing the efficiency of operations.

FRESNO, Calif. — Cypress Systems, Inc, a Fresno CA based biotechnology company, announced that it has promoted Mark E. Whitacre, Ph.D. to become the company’s Chief Operating Officer (COO) and President of Operations. Dr. Whitacre joined the executive management team in December 2006 as President of Technology and Business Development for the new east coast office.

SAN MARINO, Calif. — Epeius Biotechnologies Corporation announced today the issue of U.S. Patent No. 7,347,998 for Targeted Gene Delivery in vivo. This patent provides additional intellectual property protection for the platform of highly advanced biotechnologies embodied in the company’s leading anti-cancer agent, Rexin-G.

TEMECULA, Calif. — Written Inc. has developed a breakthrough technology which has led to the first significant improvement to the 150-year-old science of handwriting analysis. This week, the company released the latest version of their personality assessment tool, Candidate Insight(TM).

SANTA CLARA, Calif. — SecuGen is pleased to announce that Club Sentry, Inc. has chosen SecuGen’s Hamster fingerprint readers for integration with Club Sentry’s club management software. The Hamster readers will be used to scan fingerprints of members when they check-in and check-out through Club Sentry’s Biometric ID software module.

ATLANTA, Ga. — M2SYS, an award-winning biometric technology research and development firm, announced today the release of their newest fingerprint biometrics innovation: Bio-AI(TM). This exciting new artificial intelligence enhancement uses a unique “dynamic profiling” technique to learn about a person’s fingerprints over time. This knowledge enables the fingerprint software to take actions that mitigate the chance of generating a false reject following a fingerprint scan.

DALLAS, Texas — Biometric Signature ID (“BSI”) announces that its CEO, Jeff Maynard, will be a featured speaker at InnoTech, the Business & Technology Innovation Conference in San Antonio, Texas. Mr. Maynard is scheduled to speak on a very popular topic entitled “Biometric Signatures for Identity Authentication and Reduction in Identity Fraud.”

SANTA CLARA, Calif. — SecuGen Corporation, a world leading fingerprint technology company, announced today that its well-known Hamster(TM) line of fingerprint readers is now available with Tutis Biometric Logon, an Active Directory compatible network authentication application.

SANTA CLARA, Calif. — SecuGen Corporation, a world leading fingerprint technology company, today announced its collaboration with WCC Smart Search & Match, a leading provider of high-performance search and match software. WCC Smart Search & Match has developed ELISE ID, the Platform for Multi-Modal Fusion, which is capable of searching vast amounts of data,

WASHINGTON, D.C. — Backbone Security, the industry leader in advanced digital steganalysis tools, announced the latest version of their market leading Steganography Application Fingerprint Database (SAFDB) at the opening of The Computer Forensics Show in the DC Convention Center.

DALLAS, Texas — Biometric Signature ID (“BSI”) CEO Jeff Maynard announces it has signed a teaming agreement to become a member of a team led by Zolon Tech, Inc. of Sterling, Virginia that was recently awarded a prime contract for the U.S. Department of State’s Hybrid Information Technology Support Services (HITSS) program. Through the HITSS contract, this team will support the State Department’s mission at headquarters and field offices throughout the United States and internationally.

ATLANTA, Ga. — M2SYS Technology, an award-winning biometric fingerprint technology firm, announced today that LOGICARE Corporation has enhanced its OnRecord(TM) healthcare solution for emergency departments and patient educators by integrating M2SYS’ Bio-Plugin(TM) fingerprint software.

SAN MARINO, Calif. — Epeius Biotechnologies Corporation announced today their appreciation of the accomplishments of their contemporaries in 2007, a truly remarkable year in terms of biomedical research, scholarship, and gonzo journalism. It was a year in which a definitive meeting entitled “In Vivo Barriers to Gene Delivery” was held at the prestigious Cold Spring Harbor Laboratory, where Nobel laureate James Watson presides, or shall we say presided.

SAN MARINO, Calif. — Epeius Biotechnologies Corporation announced today that the company has received a Certificate of Product Registration for Rexin-G(R) from the Philippine Bureau of Food and Drugs (BFAD), enabling the commercialization of its lead product as a safe and effective treatment for a broad spectrum of intractable cancers.

SANTA CLARA, Calif. — SecuGen is pleased to announce that Bromba Biometrics BioIDENTICA SDK is now compatible with SecuGen Hamster III, Hamster Plus and Hamster IV fingerprint readers. The BioIDENTICA SDK allows a simple integration of fingerprint technology into any existing or new software application that can benefit from biometric authentication.

SANTA CLARA, Calif. — SecuGen is pleased to announce that realtime has integrated SecuGen(R) fingerprint readers with realtime’s bioLock Software to provide biometric authentication and fraud mitigation for SAP applications. To date, bioLock is the only certified technology available for ERP market leader, SAP, that offers biometric access and function control.

SANTA CLARA, Calif. — SecuGen, a world-leading provider of fingerprint recognition technology, is pleased to announce that ZK Software has selected SecuGen’s FDU02 fingerprint sensor for integration with its newly released S900 access control and time & attendance terminal.

ATLANTA, Ga. — M2SYS Technology, an award-winning biometric fingerprint technology firm, announced today that Software Techniques Inc. has enhanced their TimeKRON PC-based time and attendance software by integrating M2SYS’ Bio-SnapON(TM) solution.

SANTA CLARA, Calif. — SecuGen is proud to announce that Bioscrypt Inc. (TSX: BYT), a leading provider of identity and access management solutions, has chosen to integrate SecuGen’s fingerprint sensor into their V-Station (Optical) reader. With the introduction of the V-Station (Optical), Bioscrypt has added SecuGen’s optical sensor technology to its award-winning line of readers for physical access control.

DALLAS, Texas — Biometric Signature ID (“BSI”) announces that CEO, Jeffrey Maynard, will be a speaker at InnoTech, the Business & Technology Innovation Conference to take place at the Cox Convention Center in Oklahoma City. Mr. Maynard will speak Tuesday, November 6, at 10:00 a.m. on a very timely topic entitled “Biometric Signatures to Reduce Identity Theft and Fraud – A New Defense.”

SAN MARINO, Calif. and BOSTON, Mass. — Epeius Biotechnologies Corporation today announced that Dr. Frederick L. Hall, President and CEO of Epeius Biotechnologies Inc., has accepted an invitation to give the lead keynote address on “The Advent of Pathotropic Medicine for Cancer” at the Global Pharma R&D Summit 2007 to be held in Boston MA. On October 22, 2007 at 8:00 a.m., Dr. Hall will present the scientific principles, the clinical validation, and global development status.

DALLAS, Texas — Biometric Signature ID (“BSI”) announces that CEO, Jeffrey Maynard, will be a speaker at 2007 InnoTech Austin, the Business & Technology Innovation Conference & Expo to take place at the Austin Convention Center. Mr. Maynard will speak Thursday, October 11 at 9:00 a.m. with an innovative presentation entitled “Biometric Solutions for Identity Authentication and Identity Theft – What You Should Know.”

ATLANTA, Ga. — M2SYS Technology, a leading biometric technology research and development firm, announced today its partnership with TeraCorp Enterprises, a leading provider of check cashing and verification solutions, to integrate the M2SYS Bio-Plugin(TM) fingerprint solution into TeraCash, a cutting-edge check cashing system.

ATLANTA, Ga. — M2SYS Technology, an award-winning biometric technology research and development firm, announced today that they have partnered with Gnosis Medical Services to provide a biometric fingerprint solution for patient identification in developing countries.

SANTA CLARA, Calif. — SecuGen, a world leading optical fingerprint recognition technology company, announced today its partnership with M2SYS Technology, a biometric technology research and development firm, to support their award winning Bio-Plugin(TM) software that allows software developers to rapidly integrate a complete, server-based, turn-key fingerprint software system with hardly any development effort.

ATLANTA, Ga. — M2SYS Technology, a biometric technology research and development firm, announced today its partnership with SecuGen Corporation to support their revolutionary fingerprint reader, the Hamster Plus. The Hamster Plus fingerprint reader features innovative Auto-On technology that automatically checks for the presence of a finger.

ATLANTA, Ga. — M2SYS Technology, an award-winning biometric fingerprint technology firm, announced today that Stromberg, a subsidiary of Paychex, Inc. (NASDAQ:PAYX), and a leading provider of time and attendance solutions for mid- to large-sized businesses, has integrated M2SYS’ Bio-SnapON(TM) solution into their Web-enabled time and attendance software.

SAN MARINO, Calif. — Epeius Biotechnologies Corporation announced today that an advanced Phase I/II clinical trial using intravenous Rexin-G(TM) for pancreatic cancer that is refractory to standard chemotherapy will open in the summer of 2007 in Los Angeles, California. Rexin-G is the world’s first tumor-targeted injectable gene delivery system that is designed to seek out and destroy both primary tumors and metastatic cancers that have spread throughout the body.

ATLANTA, Ga. — M2SYS, an award-winning biometric technology research and development firm announced today that LunchByte Systems, Inc., home of the NUTRIKIDS brand of foodservice management solutions, has integrated M2SYS’ unique Bio-SnapON(TM) solution into their lunchline POS system; instantly increasing the security and efficiency of their application.

PASADENA, Calif. — Osmetech plc (LSE, AIM; OMH) today announced that it has granted a non-exclusive research license to Waltham, Massachusetts, US-based Minerva Biotechnologies Corporation (“Minerva”) for use of Osmetech’s self-assembling monolayer (SAM) technology in conjunction with Minerva’s proprietary nanoparticle technology. Osmetech is a fast developing, international molecular diagnostics business.

FRESNO, Calif. — Cypress Systems, Inc, a Fresno CA based biotechnology company, announced that it has hired Mark Whitacre, Ph.D. Dr. Whitacre joined the executive management team effective January 1, 2007 as COO & President, Technology and Business Development, following the opening of a new office in Pensacola, Florida in December, 2006.

SAN MARINO, Calif. — Epeius Biotechnologies announced the publication of a historic landmark in medical oncology and a definitive benchmark in the emerging field of cancer gene therapy. The first clinical report of its kind, Le Morte du Tumour – published in the June issue of the International Journal of Oncology, documents the histologic features of tumor destruction observed in chemo-resistant cancers.

SAN MARINO, Calif. — Epeius Biotechnologies Corporation announced today the expansion of ongoing clinical trials using Rexin-G(TM) in the United States to include breast cancer and all types of sarcomas that have failed standard chemotherapy. Following on the heels of their landmark clinical trials in the United States and abroad, the US FDA granted Orphan Drug Status for Rexin-G.

SAN MARINO, Calif. — Epeius Biotechnologies Corporation today announced that Dr. Frederick L. Hall, President and CEO of Epeius Biotechnologies, has accepted an invitation to speak during the 9th annual C21 BioVentures Conference. On May 23 at 11:15 am, Dr. Hall will present the scientific principles, clinical validation, and global development status of the company’s innovative tumor-targeting technology embodied in its lead product, Rexin-G, the first targeted genetic medicine developed to treat metastatic cancer.

ATLANTA, Ga. — Frost & Sullivan presented M2SYS Technology with its 2007 North American Biometrics Technology Innovation of the Year Award at the 2007 North American Excellence in Industrial Technologies Awards Banquet. Frost and Sullivan chose M2SYS as the recipient of this prestigious award after a year-long evaluation of products from every biometrics company in the industry.

ATLANTA, Ga. — M2SYS Technology announced today the completion of an ongoing case study with point of sale solutions partner, LCR Limited. In early 2006, LCR integrated M2SYS’ flagship fingerprint software, Bio-Plugin(TM), into their QuickDine(TM) school lunchroom management software to provide an alternative to magnetic swipe-cards that were previously used to identify students purchasing lunch.

ATLANTA, Ga. — M2SYS Technology announced today that it was selected late in 2006 by a leading Nigerian IT products provider to deliver fingerprint scanners and software for the secure national voting project. After the original local vendor selected for the project faced delays in meeting its timeline for the fulfillment of a portion of needed IT units, Nigerian government officials sought out the help of another company, who turned to M2SYS for assistance.

ATLANTA, Ga. — M2SYS Technology announced today that it has formed a strategic partnership with Schoolhouse Software, a leading provider of K-12 lunch line management systems. This partnership will benefit school customers by enabling Schoolhouse to integrate M2SYS’ market revolutionizing fingerprint software technology, Bio-Plugin(TM), within their Touch-n-Serv(TM) K-12 school lunch line POS solution.

ATLANTA, Ga. — M2SYS Technology announced today it has formed a relationship with Kodak’s Dental Systems Group to integrate M2SYS’ patent-pending fingerprint software into the KODAK ORTHOTRAC Practice Management Software. As a result, Kodak’s customers will be able to secure sensitive patient information and comply with HIPAA requirements, while improving productivity and user experience by eliminating the time, hassle, and headache associated with password management.

SAN MARINO, Calif. and MANILA, Philippines — Epeius Biotechnologies today announced the publication of clinical data from studies conducted at the University of the Philippines, Asian Hospital and Medical Center, Makati Medical Center, Manila, Philippines and Lutheran Medical Center, New York, USA, revealing the safety and single agent efficacy of Rexin-G(TM) for the treatment of a broad spectrum of chemotherapy-resistant cancers.

ATLANTA, Ga. — M2SYS Technology, a biometric technology research and development company, announced today it has formed a partnership with PCS Revenue Control Systems, a leading provider of foodservice management technology. This partnership will benefit school districts by enabling PCS to integrate and distribute M2SYS’ cutting edge fingerprint software technology, Bio-Plugin(TM), within their FASTRAK(TM) school meal software.

JESSUP, Md. — ACell, Inc., the owner of highly valued extracellular matrix (ECM) patents, along with co-defendants Dr. Stephen Badylak and Dr. Alan Spievack, today won another legal victory against Cook Biotech, Inc. (Cook) and Purdue Research Foundation (Purdue) when the Court of Appeals for the Federal Circuit denied Cook’s and Purdue’s Petition for Rehearing and Rehearing En Banc. In the Petition Cook and Purdue had requested both the original Federal Circuit three judge panel and the entire Federal Circuit Court to reconsider a detailed 29 page written opinion issued on August 18, 2006.

MECHELEN, Belgium — Responding to the need to make timely evaluations and decisions when treating treatment experienced HIV patients, Virco Labs (www.vircolab.com), a leader in drug resistance testing recently introduced an improved virco(R)TYPE HIV-1 test that rapidly determines the complex phenotypic resistance profiles for darunavir, tipranavir and other antiretroviral (ARV) drugs.

SAN MARINO, Calif. — Epeius Biotechnologies Corporation today announced that Dr. Frederick Hall, President and CEO of Epeius Biotechnologies, has accepted an invitation to speak at the upcoming Global Pharmaceutical Research & Development Summit held on Oct. 24 at 4:10 p.m. (PT) in Anaheim, Calif. Dr. Hall will present the current status of global development and the broad pharmaceutical indications for the company’s innovative targeting technology platform.

JESSUP, Md. — ACell, Inc., the owner of highly valued extracellular matrix (ECM) patents, today won a resounding legal victory against Cook Biotech, Inc. (Cook) and Purdue Research Foundation (Purdue). The victory frees ACell to broadly promote the development, licensing and commercialization of its remarkable tissue graft bio-technology.

ATLANTA, Ga. — M2SYS Technology, a leading biometric technology research and development firm, today announced a new version release of Bio-Plugin(TM), a fully developed, server-based, enterprise fingerprint recognition system that can be rapidly deployed, in many cases with no additional development whatsoever.